There have been no shortage of rumors on Clovis Oncology (NASDAQ: CLVS) since rival TESARO agreed to be acquired by ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE